List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 5 | Aged |
| 5 | Humans |
| 4 | Female |
| 4 | Male |
| 4 | Middle Aged |
| 3 | Adult |
| 3 | Double-Blind Method |
| 3 | Parkinson's disease |
| 2 | Cross-Over Studies |
| 2 | Dose-Response Relationship, Drug |
| 2 | Levodopa (therapeutic use) |
| 2 | Neurologic Examination (drug effects) |
| 2 | Parkinson Disease (drug therapy) |
| 2 | Parkinson Disease (physiopathology) |
| 2 | Progressive supranuclear palsy |
| 2 | Supranuclear Palsy, Progressive (physiopathology) |
| 2 | Treatment Outcome |
| 1 | Adrenergic alpha-Antagonists (adverse effects) |
| 1 | Adrenergic alpha-Antagonists (therapeutic use) |
| 1 | Age Factors |
| 1 | Aged, 80 and over |
| 1 | Alpha‐2 antagonist |
| 1 | Analysis of Variance |
| 1 | Antiparkinson Agents (therapeutic use) |
| 1 | Atrophy (diagnosis) |
| 1 | Atrophy (physiopathology) |
| 1 | Benzofurans (adverse effects) |
| 1 | Benzofurans (therapeutic use) |
| 1 | Blocking |
| 1 | Blood Flow Velocity (physiology) |
| 1 | Body movement |
| 1 | Brain (pathology) |
| 1 | Brain Mapping |
| 1 | Bromocriptine (adverse effects) |
| 1 | Bromocriptine (therapeutic use) |
| 1 | Cerebral Palsy (diagnosis) |
| 1 | Cerebral Palsy (physiopathology) |
| 1 | Clinical trial |
| 1 | Comparative study |
| 1 | Confidence Intervals |
| 1 | Diagnosis, Differential |
| 1 | Disability Evaluation |
| 1 | Disease Progression |
| 1 | Dominance, Cerebral (physiology) |
| 1 | Dopamine Agonists (therapeutic use) |
| 1 | Dopamine agonist |
| 1 | Double‐blind, controlled study |
| 1 | Drug Administration Schedule |
| 1 | Drug Therapy, Combination |
| 1 | Dyskinesia, Drug-Induced (drug therapy) |
| 1 | Early Parkinson's disease |
| 1 | Efaroxan |
| 1 | Emission tomography |
| 1 | Exploration |
| 1 | Freezing |
| 1 | Frontal Lobe (blood supply) |
| 1 | Frontal Lobe (radionuclide imaging) |
| 1 | Frontal lobe |
| 1 | Gait (physiology) |
| 1 | Gait disorder |
| 1 | Hemodynamics |
| 1 | Idiopathic |
| 1 | Imidazoles (adverse effects) |
| 1 | Imidazoles (therapeutic use) |
| 1 | Indoles (therapeutic use) |
| 1 | Isolated gait ignition failure |
| 1 | Levodopa |
| 1 | Levodopa (adverse effects) |
| 1 | Longitudinal Studies |
| 1 | Motor Skills (drug effects) |
| 1 | Motor symptoms |
| 1 | Multiple system atrophy |
| 1 | Muscle Rigidity (physiopathology) |
| 1 | Muscle Rigidity (radionuclide imaging) |
| 1 | Naltrexone |
| 1 | Naltrexone (adverse effects) |
| 1 | Naltrexone (therapeutic use) |
| 1 | Neurologic Examination |
| 1 | Neurons (physiology) |
| 1 | Odds Ratio |
| 1 | Parkinson Disease (diagnosis) |
| 1 | Parkinson Disease (radionuclide imaging) |
| 1 | Parkinson disease |
| 1 | Photon |
| 1 | Prospective Studies |
| 1 | Reflex, Vestibulo-Ocular |
| 1 | Regional Blood Flow (physiology) |
| 1 | Regional blood flow |
| 1 | Regression Analysis |
| 1 | Ropinirole |
| 1 | SPECT |
| 1 | Severity of Illness Index |
| 1 | Starting |
| 1 | Supranuclear Palsy, Progressive (diagnosis) |
| 1 | Supranuclear Palsy, Progressive (drug therapy) |
| 1 | Supranuclear Palsy, Progressive (radionuclide imaging) |
| 1 | Supranuclear palsy |
| 1 | Tomography, Emission-Computed, Single-Photon |
| 1 | Vestibuloocular reflex cancellation |
| 1 | Xenon Radioisotopes (diagnostic use) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Rascol"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Rascol" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Rascol
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
